Category: Funding
|
|
| |
|
California Life Science Firms to Learn "Insider" Strategies for Government Funding at 11th SoCalBio Investor & Partnership Conference
|
 |
Now, more than ever, start-ups can use all the help they can get. The San Jose BioCenter will provide your biotech or cleantech company with support for fundraising, business development, legal, lab support, HR and payroll activities, as well as, provide you with access to our $15 million dollar state-of-the-art laboratory facilities and shared equipment.
“In just 5 years San Jose BioCenter companies have raised over $1 Billion in deals and financing.” -Melinda Richter, Executive Director, San Jose BioCenter
Our mission is to provide life science and cleantech companies with the infrastructure, resources, networks and expertise they need to develop and commercialize their technology. The San Jose BioCenter was awarded the National Business Incubator Association (NBIA) International Incubator of the year award for 2009 because of our exceptional resources, programs and client success rate. After 1.5 years at the San Jose BioCenter, Tacere Pharmaceuticals inked a $145m development deal with Pfizer for its preclinical hepatitis C drug:
December 10, 2009 - an EBC event - Mountain View, California
Although VC's are a traditional source of funds, there are many opportunities for financing especially in clean energy that can get your company to where you need it to be. You just need to know the right people and get creative. Join our panel to hear from a range of creative financing avenues including private wealthy individuals, government granting agencies, foundations, angels and VCs who have opportunities for you to fund your company. Read more»
 |
|
Navigating the Life Science
Venture Industry
|
|
Friday, November 6, 2009
12:00 to 1:00 pm
Stanley Hall Room 621
|
UC SAN FRANCISCO
Corinna Kaarlela, News Director
Source: Kristen Bole (415) 476-2557
E-mail: kbole@pubaff.ucsf.edu
Web: www.ucsf.edu
FOR IMMEDIATE RELEASE
October 26, 2009
The California Institute of Quantitative Biosciences (QB3) is collaborating with a newly launched $7.5 million fund to provide startup capital for University of California bioscience entrepreneurs and a long-term endowment for QB3.
Contact
Jeanne Mell
University City Science Center
215-966-6029
PHILADELPHIA--(October 21, 2009) – A new regional Proof-of-Concept program is pumping $600,000 into technology commercialization in the Greater Philadelphia region.
The Pittsburgh Life Sciences Greenhouse (PLSG) formed in 2002 through a partnership between the University of Pittsburgh, Carnegie Mellon University, local government and private investment to spur the economic development of the region and to strengthen Pittsburgh's life sciences industry. Today PLSG provides funding and business development resources for companies that are just starting, all the way up to companies reaching full maturity.
The Commercialization Center for Innovative Technologies (CCIT) is located in the Technology Centre of New Jersey in New Brunswick. CCIT is a 46,000 square foot incubator with wet labs and office space designed to accelerate small business growth. CCIT is a designated Soft Landings Incubator by the National Business Incubator Association and provides business and marketing services through the New Jersey Economic Development Association's (EDA) Strategic Partner Advantage Network (SPAN). The Incubator provides shared facilities that include conference rooms, office equipment and autoclaves.
Date: Friday, October 9, 2009
Time: 9:30-11:30AM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: from $0 to $40
Is your small business on the brink of taking its innovative cancer research to the next level but is in need of early-stage technology financing?
Date: Friday, October 9, 2009
Time: 9:30-11:30AM
Venue: San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
Cost: from $0 to $40
Is your small business on the brink of taking its innovative cancer research to the next level but is in need of early-stage technology financing? Learn about how your company may be eligible to tap into the financial resources and new funding opportunities available from the National Cancer Institute's SBIR and STTR Programs. The SBIR and STTR Programs offer funding in nanotechnology, anti-cancer agents, biomarkers, proteomics, pharmacodynamics, and many more areas of interest to the NCI. David Beylin from the NCI SBIR Development Center will discuss the diverse SBIR and STTR funding opportunities and offer tips for applying. | Registration fee: from $0 to $40 | 9:30-11:30 | @ the San Jose BioCenter, 5941 Optical Court, San Jose CA 95138
